NasdaqCM - Nasdaq Real Time Price USD

Inhibikase Therapeutics, Inc. (IKT)

1.7100 -0.1500 (-8.06%)
At close: April 26 at 4:00 PM EDT
1.6906 -0.02 (-1.13%)
After hours: April 26 at 4:01 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
14,506.6470
24,936.2970
42,469.9990
14,782.7060
Total Liabilities Net Minority Interest
3,528.7250
3,900.8960
4,054.4500
4,998.3500
Total Equity Gross Minority Interest
10,977.9220
21,035.4010
38,415.5490
9,784.3560
Total Capitalization
10,977.9220
21,035.4010
38,415.5490
10,060.8170
Common Stock Equity
10,977.9220
21,035.4010
38,415.5490
9,784.3560
Capital Lease Obligations
240.2190
351.2870
--
--
Net Tangible Assets
10,977.9220
21,035.4010
38,415.5490
9,784.3560
Working Capital
10,772.4470
20,675.6770
38,415.5490
10,060.8170
Invested Capital
10,977.9220
21,035.4010
38,664.4600
10,103.3510
Tangible Book Value
10,977.9220
21,035.4010
38,415.5490
9,784.3560
Total Debt
240.2190
351.2870
248.9110
318.9950
Share Issued
6,186.2800
4,204.5080
4,192.5330
1,675.1410
Ordinary Shares Number
6,186.2800
4,204.5080
4,192.5330
1,675.1410
12/31/2020 - 12/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers